Osteopore Limited (OSX.AX)

0.0580 0.0000 (0.00%) At close: 03:14PM AEST

Osteopore Limited

191 Street Georges Terrace
Level 5
Perth, WA 6000
Australia
61 2 8072 1400
https://www.osteopore.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kei Wei Leong	Executive Chairman	150k	N/A	1976
Dr. Yujing Lim	CEO & CTO	202.25k	N/A	N/A
Ms. Shu Ning Voon	Financial Controller	N/A	N/A	N/A
Mr. Khoon Seng Goh	Global Marketing Director	212.9k	N/A	N/A
Ms. Kellie Davis	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development. Osteopore Limited was incorporated in 2018 and is headquartered in Perth, Australia.

Corporate governance

Osteopore Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.